Veracyte Inc. (VCYT)
VCYT trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$43.11
-2.07% on the day
Market cap
$3.5B
Mid cap
Revenue · 2025
$517.1M
+16.0% on 2024
Net income · 2025
$66.4M
12.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | VCYT on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | 2013 |
| SEC CIK | 0001384101 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $517.1M |
| Net income | $66.4M |
| Operating income | $57.8M |
| Net margin | 12.8% |
| Operating margin | 11.2% |
| Revenue growth | +16.0% |
| Cash | $362.6M |
| Total assets | $1.4B |
| P/E (computed) | 52.2× |
| P/S (computed) | 6.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2024-03-22 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-07-31 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.4% |
| 1 month | +7.9% |
| 3 months | -26.8% |
| Year to date | +2.9% |
| 1 year | +27.1% |
| From 52-week high | -28.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CDNA | CareDx Inc. | $65.43 | +3.66% | $3.4B |
| CELC | Celcuity Inc. | $63.19 | -4.04% | $3.1B |
| ACHC | Acadia Healthcare Company Inc. | $30.23 | +0.50% | $2.8B |
| BLLN | BillionToOne Inc. | $94.44 | +1.47% | $4.5B |
| CLOV | Clover Health Investments Corp. | $4.81 | +0.63% | $2.6B |
| CON | Concentra Group Holdings Parent Inc. | $37.54 | 0.00% | $4.8B |
| RDNT | RadNet Inc. | $71.51 | +0.03% | $5.6B |
| FTRE | Fortrea Holdings Inc. | $20.92 | -0.38% | $2.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier